BACKGROUND: Interaction of sex hormone-binding globulin (SHBG) and oxytocin (OT) is among the factors that control smooth muscle proliferation and tumor growth through the oxytocin receptor (OTR). Also, a close functional interaction of OTR and caveolin-1 has been shown to modulate cell growth and proliferation. METHODS: We studied surgical samples from 23 leiomyoma patients (aged 33-66 years) with immunocytochemistry. Specimens from five patients (34-76 years), who had hysterectomy for other reasons, served as controls. Tissue samples were cut into serial 1-microm thick sections for co-localization of SHBG, OTR, proliferation marker p21 and caveolin-1. RESULTS: SHBG was found in smooth muscle cells in all samples. OTR staining occurred in most of these cells in myomas, while controls contained only scattered cells positive for OTR. There were no apparent differences in immunostaining for p21, while immunoreactivity for caveolin-1 was observed in most cells in myomas and in only few cells in controls. Caveolin-1 was mostly co-localized with SHBG and OTR in myoma samples whereas controls showed this co-localization only occasionally. CONCLUSIONS: Our observations indicate an interaction of SHBG and OTR, associated with caveolin-1, which may account in part for known non-genomic actions of ovarian steroids. Growth of leiomyomas may be linked to these mechanisms.
BACKGROUND: Interaction of sex hormone-binding globulin (SHBG) and oxytocin (OT) is among the factors that control smooth muscle proliferation and tumor growth through the oxytocin receptor (OTR). Also, a close functional interaction of OTR and caveolin-1 has been shown to modulate cell growth and proliferation. METHODS: We studied surgical samples from 23 leiomyomapatients (aged 33-66 years) with immunocytochemistry. Specimens from five patients (34-76 years), who had hysterectomy for other reasons, served as controls. Tissue samples were cut into serial 1-microm thick sections for co-localization of SHBG, OTR, proliferation marker p21 and caveolin-1. RESULTS:SHBG was found in smooth muscle cells in all samples. OTR staining occurred in most of these cells in myomas, while controls contained only scattered cells positive for OTR. There were no apparent differences in immunostaining for p21, while immunoreactivity for caveolin-1 was observed in most cells in myomas and in only few cells in controls. Caveolin-1 was mostly co-localized with SHBG and OTR in myoma samples whereas controls showed this co-localization only occasionally. CONCLUSIONS: Our observations indicate an interaction of SHBG and OTR, associated with caveolin-1, which may account in part for known non-genomic actions of ovarian steroids. Growth of leiomyomas may be linked to these mechanisms.
Authors: R Calderon-Margalit; S M Schwartz; M F Wellons; C E Lewis; M L Daviglus; P J Schreiner; O D Williams; B Sternfeld; J J Carr; D H O'Leary; S Sidney; Y Friedlander; D S Siscovick Journal: J Clin Endocrinol Metab Date: 2010-06-16 Impact factor: 5.958
Authors: Alicia B Moore; Linda Yu; Carol D Swartz; Xaiolin Zheng; Lu Wang; Lysandra Castro; Grace E Kissling; David K Walmer; Stanley J Robboy; Darlene Dixon Journal: Cell Commun Signal Date: 2010-06-10 Impact factor: 5.712
Authors: Sílvia Xargay-Torrent; Gemma Carreras-Badosa; Sara Borrat-Padrosa; Anna Prats-Puig; Pilar Soriano; Elena Álvarez-Castaño; Mª Jose Ferri; Francis De Zegher; Lourdes Ibáñez; Abel López-Bermejo; Judit Bassols Journal: PLoS One Date: 2018-10-15 Impact factor: 3.240